GlassScriptPhysician profile
Heather A Carl
NPI 1881602274
$2,806.20
in general payments reported to CMS, 2019-2025
14 companies · $568 in 2025
The $568 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $598 · 2022: $546 · 2023: $185 · 2024: $909 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $807.66 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $463.51 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $442.00 | 2022-2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $322.41 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $303.49 | 2021-2025 | Relistor |
| Forte Bio-Pharma LLC | $292.19 | 2022-2024 | Prolate, Nalocet |
| Almatica Pharma LLC | $29.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.80 | 2023 | Seglentis |
| Pfizer INC. | $25.02 | 2021 | |
| Biotronik Nro, INC. | $23.95 | 2025 | Prospera |
| Curonix LLC | $20.24 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $17.16 | 2025 | Movantik |
| Nevro Corp. | $16.40 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Carl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.